Case Report

Long-term Survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer
  • Bülent Karagöz
  • Alpaslan Özgün
  • Levent Emirzeoğlu
  • Tolga Tunçel
  • Serkan Çelik
  • Oğuz Bilgi
  • Kemal Kara
Eur J Breast Health 2015; 11: 48-51 DOI: 10.5152/tjbh.2014.2009
RECURRENT SUPRAVENTRICULAR TACHYCARDIA ASSOCIATED WITH LAPATINIB: A CASE REPORT OF A PROBABLE CARDIAC ADVERSE EFFECT
  • Özgür Tanrıverdi
  • Nezih Meydan
  • Sabri Barutca
Eur J Breast Health 2011; 7: 188-190

Original Article

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine
  • İzzet Doğan
  • Nail Paksoy
  • Naziye Ak
  • Sezai Vatansever
  • Pınar Saip
  • Adnan Aydıner
Eur J Breast Health 2023; 19: 128-133 DOI: 10.4274/ejbh.galenos.2023.2022-12-4 PMID:37025570

Letter to the Editor

Lapatinib? or Radiotherapy? In Cranial Metastasis of Breast Cancer
  • Yasemin Benderli Cihan
Eur J Breast Health 2019; 15: 205-206 DOI: 10.5152/ejbh.2019.4874